Literature DB >> 6273635

Inhibition of adenovirus oncogenicity in hamsters by adeno-associated virus DNA.

L M de la Maza, B J Carter.   

Abstract

Adeno-associated virus (AAV) DNA partially inhibited in Syrian golden hamsters the formation of tumors by the human adenovirus (Ad) type 12. Furthermore, defective interfering AAV particles or their DNA also reduced tumorigenesis. Defective AAV particles contain aberrant genomes with extensive deletions of the internal AAV DNA sequences. Variant AAV DNA, containing 30% of the viral genome, decreased the incidence of Ad-induced tumors from 44 to 18%. Defective AAV particles, which have a buoyant density of 1.32 g/cm3 in CsCl and which are highly enriched for the DNA of the terminal regions (map positions, 0-5 and 95-100), completely suppressed Ad oncogenicity. This observation suggested that the AAV DNA sequences close to the terminal region of the genome mediated the inhibition of the Ad oncogenicity.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6273635

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  25 in total

1.  Infection of primary cells by adeno-associated virus type 2 results in a modulation of cell cycle-regulating proteins.

Authors:  J Hermanns; A Schulze; P Jansen-Db1urr; J A Kleinschmidt; R Schmidt; H zur Hausen
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

Review 2.  Parvovirus replication.

Authors:  K I Berns
Journal:  Microbiol Rev       Date:  1990-09

Review 3.  The good viruses: viral mutualistic symbioses.

Authors:  Marilyn J Roossinck
Journal:  Nat Rev Microbiol       Date:  2011-01-04       Impact factor: 60.633

4.  Regulation of adeno-associated virus gene expression in 293 cells: control of mRNA abundance and translation.

Authors:  J P Trempe; B J Carter
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

5.  Origin of adeno-associated virus DNA replication is a target of carcinogen-inducible DNA amplification.

Authors:  A O Yalkinoglu; H Zentgraf; U Hübscher
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

6.  Birth of a new therapeutic platform: 47 years of adeno-associated virus biology from virus discovery to licensed gene therapy.

Authors:  Terence R Flotte
Journal:  Mol Ther       Date:  2013-11       Impact factor: 11.454

7.  Selective killing of transformed rat cells by minute virus of mice does not require infectious virus production.

Authors:  E Guetta; M Mincberg; S Mousset; C Bertinchamps; J Rommelaere; J Tal
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

8.  Characterization of cell lines that inducibly express the adeno-associated virus Rep proteins.

Authors:  Q Yang; F Chen; J P Trempe
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

9.  Adeno-associated virus Rep protein inhibits human immunodeficiency virus type 1 production in human cells.

Authors:  B A Antoni; A B Rabson; I L Miller; J P Trempe; N Chejanovsky; B J Carter
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

10.  Parvoviruses are inefficient in inducing interferon-beta, tumor necrosis factor-alpha, or interleukin-6 in mammalian cells.

Authors:  J R Schlehofer; M Rentrop; D N Männel
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.